PEDIATRICS Vol. 110 No. 5 November 2002, pp. 884-888
Effect of Supplemental Oxygen on Sleep Architecture and Cardiorespiratory Events in Preterm Infants





* Constance S. Kaufman Pediatric Pulmonary Research Laboratory, Department of Pediatrics, Tulane University School of Medicine, New Orleans, Louisiana
Comprehensive Sleep Medicine Center, Tulane University Hospital and Clinics, New Orleans, Louisiana
Kosair Childrens Hospital Research Institute and Division of Pediatric Sleep Medicine, Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky
--> Objective. To investigate the effect of low-flow supplemental oxygen (SupOx) on sleep architecture and cardiorespiratory events in asymptomatic preterm infants.
Methods. An overnight polysomnographic evaluation was conducted prospectively in 23 premature infants who were born at 30.0 ± 3.2 (standard deviation) weeks gestational age and studied at 38.1 ± 4.4 weeks postconceptional age. Infants were free of any adverse events, including cardiorespiratory monitor alarms in the nursery for at least 1 week before the study. Infants received room air (RA) or SupOx via nasal cannula at 0.25 L/min.
Results. Quiet sleep density was increased during SupOx (33.3 ± 10.8% vs 26.6 ± 10.0% total sleep time [TST] in RA), and a reciprocal decrease in active sleep density was observed (61.5 ± 11.1% vs 68.4 ± 9.9% TST in RA). No differences in sleep efficiency emerged (69.7 ± 10.6% SupOx vs 69.7 ± 8.8% RA). SupOx elicited significant decreases in apnea index (3.8 ± 2.4 events/h vs 11.1 ± 6.4 events/h in RA) and in the percentage of time spent in periodic breathing (1.8 ± 2.9% vs 6.7 ± 8.9% in RA). In addition, SupOx decreased the frequency of bradycardic events (0.3 ± 0.8 events vs 2.5 ± 0.03 events in RA) and improved overall oxygen saturation (98.7 ± 1.1% vs 96.4 ± 2.2%). No changes in alveolar ventilation, as derived from end-tidal CO2 measurements, was detected (38.6 ± 5.8 mm Hg in SupOx vs 38.4 ± 5.4 mm Hg in RA).
Conclusions. Asymptomatic preterm infants exhibit frequent and potentially clinically adverse cardiorespiratory events when assessed in the sleep laboratory. Administration of SupOx to these infants is associated with an increase in the overall duration and percentage TST spent in quiet sleep with reciprocal changes in active sleep. In addition, improvement in respiratory stability is observed with the use of low-flow SupOx, as evidenced by a decrease in apnea, periodic breathing, and bradycardia, without adverse effects on alveolar ventilation.
Key Words: apnea of prematurity supplemental oxygen infant sleep bradycardia prematurity
Abbreviations: SupOx, supplemental oxygen CNLD, chronic neonatal lung disease REM, rapid eye movement FIO2, fraction of inspired oxygen RA, room air AS, active sleep QS, quiet sleep IS, indeterminate sleep TST, total sleep time AI, apnea index ROP, retinopathy of prematurity
Received for publication Nov 27, 2001; Accepted Apr 3, 2002.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
D Quine and B J Stenson Does the monitoring method influence stability of oxygenation in preterm infants? A randomised crossover study of saturation versus transcutaneous monitoring Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2008; 93(5): F347 - F350. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Khemani, D. B. McElhinney, L. Rhein, O. Andrade, R. V. Lacro, K. C. Thomas, and M. P. Mullen Pulmonary Artery Hypertension in Formerly Premature Infants With Bronchopulmonary Dysplasia: Clinical Features and Outcomes in the Surfactant Era Pediatrics, December 1, 2007; 120(6): 1260 - 1269. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Y. Bhat, S. Hannam, R. Pressler, G. F. Rafferty, J. L. Peacock, and A. Greenough Effect of Prone and Supine Position on Sleep, Apneas, and Arousal in Preterm Infants Pediatrics, July 1, 2006; 118(1): 101 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Beckerman Physiologically Redefining Bronchopulmonary Dysplasia Pediatrics, March 1, 2005; 115(3): 830a - 831. [Full Text] [PDF] |
||||
![]() |
I M Balfour-Lynn, R A Primhak, and B N J Shaw Home oxygen for children: who, how and when? Thorax, January 1, 2005; 60(1): 76 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sawnani, T. Jackson, T. Murphy, R. Beckerman, and N. Simakajornboon The Effect of Maternal Smoking on Respiratory and Arousal Patterns in Preterm Infants during Sleep Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 733 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Askie and W. Tin The Use of Oxygen in Neonatal Medicine: Half a Century of Uncertainty NeoReviews, December 1, 2003; 4(12): e340 - 348. [Full Text] [PDF] |
||||
![]() |
L. M. Askie, D. J. Henderson-Smart, L. Irwig, and J. M. Simpson Oxygen-Saturation Targets and Outcomes in Extremely Preterm Infants N. Engl. J. Med., September 4, 2003; 349(10): 959 - 967. [Abstract] [Full Text] [PDF] |
||||











